r e p o r t t o o u r c o m m u n i t i e s

Full text


w e

a r e

n y b c


As a

Center of Excellence

, our strength lies in collaboration with

supporters like you to provide safe, reliable, cutting-edge blood

products and services and fulfill a vital community need.


c o n t e n t s

2 | Quality, Service, Innovation, Leadership, Impact

4 | From the President & Chairman

6 | Medical Programs & Services

8 | Operations & Manufacturing

10 | Customer Service

12 | Quality & Regulatory Affairs

14 | National Cord Blood Program

16 | Lindsley F. Kimball Research Institute

18 | Corporate & Community Relations

20 | NYBC Leadership

22 | Blood Donation Centers

y o u

a r e

n y b c


At the core of our exceptional service is the dedication of

employ-ees, volunteers, donors, and community and corporate partners

whose efforts provide the gift of life. For this, we thank you.


New York Blood Center

is the single

largest nonprofit, community-based

blood collection and distribution

organization in the United States.

Since 1964, we have fulfilled a

life-saving mission

to provide the

high-est quality blood and stem cell

prod-ucts, donor and patient medical

services, and innovative research.

Our vision is to develop people

and partnerships and continue to

be recognized as a comprehensive

center of excellence worldwide.

Front Cover: In June 2006, when she was only four years old, Simone Schultz was diagnosed with acute lymphocytic leukemia. She received red cell and platelet transfusions from seven anonymous donors at Maria Fareri Children’s Hospital in Hudson Valley, New York. Each donor helped Simone win her fight against cancer.


Through the combined efforts of our geographic blood

ser-vices operations, approximately

2,000 units

of blood

products are collected each day and distributed to more than

20 million


in New York City, Long Island, the

Hudson Valley, New Jersey, Connecticut, and Pennsylvania.

Our impact

is local, national, and global. We provide


1 million blood products

a year to meet the

daily transfusion needs of cancer and surgery patients, accident

and burn victims, newborns and mothers delivering babies,

AIDS and sickle cell anemia patients, organ transplant

recipi-ents, and many others. We are also home to the National Cord

Blood Program at the Howard P. Milstein National Cord Blood

Center, the oldest, largest public cord blood bank in the world.


l e a d e r s h i p


i m p a c t


f r o m

t h e

p r e s i d e n t


c h a i r m a n

New York Blood Center was honored

with a 2009 Buildings magazine ‘Project

Innovations’ Award for operational

excel-lence in buildings, receiving Grand Prize

in the modernization categor y for the

transformation of this 75,000 square foot

warehouse into a state -of-the -ar t blood

processing and research facility.



t starts with one person’s selfless act of generosity. Communities are strengthened and lives are saved every day when blood donors give patients like Simone Schultz a chance to survive and thrive. At four years old, Simone was diagnosed with acute lymphocyt-ic leukemia. She received red cell and platelet transfusions at Westchester Medical Center’s Maria Fareri Children’s Hospital in Hudson Val-ley, New York. New York Blood Center (NYBC) is honored to serve as a lifeline for Simone and other patients who bravely face devastating illness and accidents with courage and vigor. We are resolute in our commitment to the health and vitality of those whose lives de-pend on us.

From transplants to heart surgeries, today’s advanced medical care relies on blood trans-fusions. NYBC has a longstanding tradition of providing blood products and services to the 20 million residents living in the greater met-ropolitan area. Thousands of men, women, and children need donated blood products each day, and this need could not be met without the dedication of volunteers, blood donors, contributors, and community and cor-porate partners.

We continue to build on a lifesaving legacy of quality, service, innovation, and leadership. Strong, effective leadership coupled with the outstanding contributions and generosity of all those who make the work we do possible, means our organization is well positioned to remain a Center of Excellence in the communi-ties we serve.

This report reveals what makes NYBC a lead-ing Center of Excellence in blood banking: the strength of our exemplary leadership team and staff and the power of our communities united in commitment, purpose, and action.

Collaboration and partnerships build on our success to directly benefit countless patients. Corporate and community outreach initiatives like our Little Doctors® Program and Student Scholarship Program educate young people and inspire them to a future in leadership, sci-ence, and public service. We reach medically underserved communities through our Pre-ciseMatch® blood type diversity programs as well as Project ACHIEVE, an initiative of NYBC’s Laboratory of Infectious Disease Prevention, which conducts behavioral intervention trials and research studies as part of an international effort to discover a preventive HIV vaccine. Through research advancements, our impact is wide-ranging and far-reaching. The National Cord Blood Program at NYBC’s Howard P. Mil-stein National Cord Blood Center is the single largest public cord blood bank in the world, and groundbreaking research at our Lindsley F. Kimball Research Institute continues to lead the way in blood disease prevention, treat-ments, cures, and therapies.

We are NYBC. You are NYBC. Together, we will carry on the tradition of excellence in all that we do. We value the confidence and trust you place in us and will do our best to continue to earn that trust now and in the future. Sincerely,

Howard P. Milstein

Chairman, Board of Trustees

Christopher D. Hillyer, MD President & CEO

Christopher D. Hillyer, MD

President & CEO Chairman, Board of TrusteesHoward P. Milstein


m e d i c a l

p r o g r a m s


s e r v i c e s

Radhika Sawh receives regular blood transfusions at Winthrop Hospital Cancer Center for Kids in Mineola, New York.


| 7

w h a t

w e

d o

m i l e s t o n e s

Radhika Sawh requires red cell blood transfusions to treat Thalassemia, a genetic disorder that oc-curs when red blood cells cannot make sufficient amounts of the major components of the hemo-globin protein which carries oxygen throughout the body. With a rapidly changing healthcare environment, shifts in demand, and greater com-petition, ensuring a sufficient blood supply to meet the daily needs of patients like Radhika can be challenging. NYBC aims to meet these chal-lenges every day through our innovative medical programs and services. With a well-established, growing medical agenda, we provide education to patients, physicians, and researchers and man-age transfusion services for hospital partners. Our Clinical Services Program provides more than 8,500 highly specialized patient care procedures each year, and our Hemophilia Services Program ensures over 500 local patients with hemophilia and other blood clotting disorders have access to the clotting factors they need to survive 24 hours a day, seven days a week. NYBC’s Special Donor and Community Health Services health outreach

initiatives include a Cardiovascular Disease Risk Screening project and Hereditary Hemochroma-tosis Phlebotomy Program. Our experienced clini-cians notify and counsel donors of any result that will defer them from donating blood temporarily or permanently; provide counseling and informa-tion about follow-up care and available resources; and explore treatment options and support ser-vices available to donors and their families. Our Bone Marrow Registry Program works in con-junction with the Be The Match Registry®, oper-ated by the National Marrow Donor Program, to provide bone marrow grafts for transplantation to patients suffering from leukemia and other life-threatening diseases. We recruit potential unrelat-ed, volunteer bone marrow and peripheral blood stem cell donors to join the national registry and guide them through the process of further testing and donation, should they be called as a match for a patient. In 2010, we surpassed 1,000 dona-tions coordinated through the program which continues to support the needs of patients in our communities and worldwide.

For over 30 years, the Professional Education Department has sponsored an

X Accreditation Council

for Graduate Medical Education (ACGME) Transfusion Medicine Fellowship Program.

Our Cellular Therapy Laboratory is a pioneer in personalized medicine. Bone marrow transplanta-X

tion can cure blood malignancies like leukemia and genetic disorders such as sickle cell disease. Successful transplantation depends on availability of quality hematopoietic stem cell (blood form-ing) products. Each year, the laboratory processes, cryopreserves, stores, and releases for trans-plantation more than 600 unique products for individual patients.

Since 2005, NYBC’s PreciseMatch® Program has accurately matched donated blood with patients X

in need, going beyond typical A, B, and O blood typing to ensure our multicultural patient popula-tion has access to a more diverse supply of blood products.

“Delivering the highest quality blood products

and services to meet the critical needs of patients

like Radhika is our number one priority.”

Beth Shaz, MD


o p e r a t i o n s


m a n u f a c t u r i n g

NYBC component laboratory where blood is separated into red cells, platelets, and plasma to benefit several patients.



w h a t

w e

d o

m i l e s t o n e s

NYBC continues to build on our commitment to cost efficiency and customer service through the creation of a new organizational structure. We have merged our former Core Operations and Blood Services divisions to align ourselves along functional lines and take advantage of the ex-pertise that exists within our leadership. The new entity, Operations and Manufacturing, now en-compasses donor marketing and recruitment, col-lections and core operations, operations support, logistics, and shared services. Operations and Manufacturing is an essential, central function of NYBC, implementing best practices in blood col-lection, manufacturing, and distribution. We turn donations into blood products through our two component processing laboratories in Westbury and Long Island City, New York. Operations and Manufacturing includes all blood testing labora-tories such as the Laboratory of Immunohematol-ogy and Genomics which identifies blood group antigens and antibodies; provides antigen-nega-tive red cells; educates NYBC fellows, visiting

phy-sicians, and other visitors; and serves hospitals in our regions as well as national and international laboratories. The Frozen Blood Laboratory is an integral part of NYBC, providing rare products to patients in need of highly categorized antigen-negative blood. The laboratories maintained within Operations and Manufacturing perform quality control on our blood products to ensure their safety, quality, integrity, purity, and potency, working directly with our hospital customers and Client Services Department which plays a critical role as a single point of access for our hospital cus-tomers to order specialty products such as HLA-matched platelets and life-saving granulocyte products. Another primary focus of Operations and Manufacturing is investing in new systems that better support our operations, planning, and decision-making. Process improvement is ongo-ing as we identify, analyze, and improve existongo-ing organizational processes to benefit patients on a local, national, and global scale.

The Laboratory of Immunohematology and Genomics, one of the world’s leading reference labo-X

ratories, together with the Laboratory of Immunochemistry, pioneered the use of DNA analysis as an adjunct to serological testing. Under the leadership of Director Connie Westhoff, SBB, PhD, the lab continues to identify new blood group antigens and support patient needs.

Blood banking industry leaders from Brazil and China visited our state-of-the-art Long Island City X

facility in 2009. International visitors learn more about how NYBC lab operations can help improve blood manufacturing around the globe.

For hospital blood banks, summer months are usually a time of increased demand and decreased X

supply, but 2009 marked the first year NYBC did not issue a summer emergency appeal for donors and maintained an adequate supply of blood products to meet patient needs. The hard work and dedication of our employees helped us achieve this milestone, and we salute them.

“We constantly seek to implement processes

and procedures that help us achieve optimal

operational efficiency.”

Elizabeth J. McQuail

Senior Vice President Operations & Manufacturing


c u s t o m e r

s e r v i c e

Blood recipient Heather McNamara attends a blood drive in her honor which yielded 116 units of blood and red cells.


| 11

w h a t

w e

d o

m i l e s t o n e s

In 2005, Heather McNamara was diagnosed with an abnormal inflammatory myofibroblastic tumor that cut off circulation to her major organs. Prior to surgery, Heather received oral and intravenous chemotherapy, and blood transfusions were re-quired to maintain her blood and platelet count. She needed an additional eight pints of blood during her 23-hour operation. Heather, and pa-tients like her, is what drives our commitment to exemplary customer service. It is NYBC‘s top prior-ity to continuously improve and enhance the ser-vice and support we provide while maintaining the highest degree of care and professionalism. We proactively seek to build lasting relationships with our donors and volunteers as well as hospi-tals and other organizations we partner with to ensure the continued success of our customer relationships. An organization’s most important asset is its customers. Without them, we could

not provide the essential services our communi-ties have come to expect from NYBC. As a Center of Excellence, we aim to anticipate, meet, and ex-ceed community needs and deliver quality blood products and services that save lives. Customer service leadership is key to further developing and improving NYBC’s internal and external com-munication efforts in alignment with our strategic goals and objectives. We focus on these elements because we understand how critical they are to our success and the health of the communities we serve. In all ways, we pursue true service ex-cellence to touch the lives of individuals who rely on the generosity of the 2,000 volunteer donors needed each day to give the gift of life through blood donation. NYBC is proud to serve as a strong patient advocate and trusted community partner today to ensure a healthier tomorrow.

Each year, the Association of Donor Recruitment Professionals (ADRP), an international organiza-X

tion dedicated to providing education, development, and resources for blood donor recruitment professionals, recognizes the innovation of organizations dedicated to advancing its mission. Our 2009 media campaign The Firefighter and the Doctor-Why Blood Donation Matters, produced by NYBC’s Corporate Communications Department, was honored with a 2010 ADRP Television Public Service Announcement of the Year Award. The campaign featured NYBC President and CEO Chris-topher D. Hillyer, MD, along with Matt Long, New York City firefighter, blood recipient, and donor (pictured below).

NYBC will launch a new Customer Service Call Center designed to provide customers with a X

central point of contact and meet the need for reliable, dependable, and consistent customer service and support.

The NYBC Customer Service Team has been established to further build and strengthen customer X

relationships, educate customers about NYBC products and services, and broaden face-to-face communication with all levels of our growing customer base.

“Cultivating and investing in our customer

relationships is paramount to NYBC’s life-saving


Robert Purvis

Vice President Customer Service


q u a l i t y


r e g u l a t o r y

a f f a i r s

Laboratory technicians process blood components at NYBC’s state-of-the-art facility in Long Island City, New York.


| 13

w h a t

w e

d o

m i l e s t o n e s

NYBC’s strong commitment to quality is reflected in our mission and vision, and our operations and medical senior management teams are actively engaged with Quality and Regulatory Affairs (QRA) in all matters pertaining to quality. Blood banking is perhaps one of the most regulated industries in the United States. QRA provides oversight, guidance, and support to all other operations at NYBC, ensuring the products and services we produce are of the highest possible quality. QRA staff maintain a cooperative relation-ship and regular communication with all inspec-tional agencies. As a licensed blood center, NYBC must comply with federal and state regulations and is inspected frequently by the Food and Drug Administration (FDA) and both the New York and New Jersey Departments of Health. NYBC is ac-credited by American Association of Blood Banks (AABB), the professional organization for transfu-sion medicine and related cellular therapies, as well as by FACT, the Foundation for the Accredi-tation of Cellular Therapies. Compliance with the

regulations and standards of these organizations is a major QRA priority. We have a thorough inter-nal audit program where both routine and special focused audits are used to proactively improve the quality of our processes and services. Train-ing and development of staff is critical to NYBC’s success. A part of QRA, the Training and Devel-opment Department works with management to ensure robust training programs are in place and all staff are well trained for the tasks they per-form. There are continuing education opportuni-ties and annual training updates in critical areas such as safety, compliance, and ethics. The safety of our staff, donors, and visitors is of primary im-portance. The Environmental Health and Safety Department of QRA ensures NYBC is compliant with all applicable regulations and standards, and through localized Safety Committees, we conduct

routine safety inspections of all our facilities. We

also maintain an Emergency Preparedness Plan, and staff are trained in how to respond promptly and effectively to a wide variety of emergencies.

QRA will develop and implement an online learning management system to track training for X

NYBC staff as well as serve as a vehicle for the dissemination of online training.

The QRA team will create a more robust internal audit group with independent auditors to X

improve NYBC operations by evaluating and assessing significant new or changing services, processes, operations, and controls concurrent with their development and implementation. Both NYBC’s Emergency Preparedness Plan and Quality Manual have undergone extensive evalua-X

tion, revisions, and updates. The Quality Manual provides a description of NYBC operations from a quality standpoint, and as an adjunct to the manual, a Quality Plan has been developed to outline a timeline for closing any gaps in quality.

“We are dedicated to managing quality

efficiently, systematically, and proactively in the

daily operations of New York Blood Center.”

Eva Quinley, MS, MT(ASCP)SBB Senior Vice President


l i n d s l e y



k i m b a l l

r e s e a r c h

i n s t i t u t e

With so many health conditions closely tied to blood, LFKRI is at the forefront of some of the world’s most vital research.



w h a t

w e

d o

m i l e s t o n e s

Lindsley F. Kimball Research Institute’s (LFKRI) world-renowned scientists lead some of the most innovative hematology and transfusion medicine research in the world. Our research has paved the way for new blood-related products, techniques, and therapies as well as numerous landmark pat-ents. LFKRI is home to nearly 100 scientists and staff in more than a dozen laboratories working to discover life-saving solutions that result in im-proved patient outcomes, breakthrough cures, and advanced treatment for an array of blood-re-lated diseases. Our laboratories develop novel ap-proaches to treating infectious and blood-borne illnesses, immune system disorders, and red cell

and platelet diseases. Researchers work in a range of areas, including biochemistry, molecular and cell biology, genetics, gene therapy, virology, and immunology. This crucial research impacts all areas of science, blood-related conditions, and transfusion medicine. We continue to research global health threats and work toward develop-ing treatments for malaria, sickle cell disease, and severe acute respiratory syndrome (SARS). From the discovery of the first HIV-fusion inhibitor to treat AIDS to the development of a solvent deter-gent which inactivates viruses in blood plasma, LFKRI has made an indelible mark on transfusion medicine.

LFKRI is a leader in AIDS research, conducting clinical trials of candidate HIV vaccines and de-X

veloping strategies for changing the behavior of at-risk populations. Established in 1993 as part of LFKRI’s Laboratory of Infectious Disease Prevention and under the leadership of Beryl Koblin, PhD, Project ACHIEVE advances awareness of HIV prevention, developing detailed epidemiologi-cal studies on the prevalence of HIV infection in New York City.

LFKRI scientists have molecularly characterized a number of clinically relevant red cell blood group X

antigens which could potentially lead to the development of DNA-based typing of blood and im-proved transfusion practices.

NYBC’s Office of Patents and Licensing manages more than 200 patents and patent applications X

derived from research conducted at LFKRI, leading to new products and processes that signifi-cantly improve patient care.

LFKRI is a part of the Myeloproliferative Disorders Research Consortium, an international group of X

researchers working to better understand the causes of myeloproliferative disorders (MPD) and develop improved methods of diagnosis and treatment. MPD’s are conditions that cause blood cells (platelets and white and red blood cells) to grow abnormally in the bone marrow. Further knowledge about these cancer cells and the effects of treatment may lead to improvements in current therapies and the development of entirely new treatments.

“Our research efforts propel blood and

blood-related disease knowledge and discoveries to

new heights.”

Mohandas Narla, DSc

Vice President


n a t i o n a l

c o r d

b l o o d

p r o g r a m

Cord blood units are processed for transplantation and research at NYBC’s National Cord Blood Program laboratories.


| 17

w h a t

w e

d o

m i l e s t o n e s

It was more than 17 years ago when the National Cord Blood Program (NCBP) at NYBC’s Howard P. Milstein National Cord Blood Center opened its doors to serve the global community as the first public cord blood bank in the world. With over 55,000 donations and more than 4,100 patients transplanted at 220-plus transplant centers world-wide, we continue to advance the use of umbili-cal cord blood as a potential treatment for many diseases. Umbilical cord blood units are now used as a possible treatment for over 65 conditions, including acute leukemia, lymphoma, sickle cell anemia, and other lethal diseases of the blood or immune system. Our work helps patients whose only chance of survival is a transplant that

replac-es the diseased cells in their bone marrow with healthy cells. NYBC pioneered the use of umbilical cord blood as a source of hematopoietic (blood-forming) stem cells for bone marrow restoration. After a baby is born and the umbilical cord is cut, blood the baby no longer needs remains in the placenta and umbilical cord. This cord blood can be collected after the placenta is delivered with-out risk to the mother or baby. Studies indicate that cord blood transplants may work well even when not perfectly matched to patients, which would be a special benefit for those with rare tissue types, including patients from ethnically diverse populations.

Cord blood is currently considered an experimental source of hematopoietic stem cells. However, X

The New England Journal of Medicine featured NCBP’s study of results from its first 562 transplant recipients, showing cord blood transplants may be useful for patients with certain disease states. A groundbreaking NCBP study led by Andromachi Scaradavou, MD, and colleagues from NYBC X

and Leiden University in the Netherlands, showed how matching non-inherited maternal anti-gens (NIMA) with mismatched donor leukocyte antianti-gens may improve the outcome of cord blood transplants. Thus, NIMA may augment the number of matches for patients. The study was pub-lished by the Proceedings of the National Academy of Sciences (November 9, 2009); featured in the December 1, 2009 edition of the American Society for Blood and Marrow Transplantation’s ASBMT eNews; and in the December 7, 2009 Time magazine article “The Year in Health From A to Z.” In addition to clinical therapies, NCBP makes cord blood units (CBUs) available for stem cell X

research. Research-use CBUs are donated by the mother after being notified that the unit does not meet criteria for transplantation. Between 2008 and 2009, NYBC provided nearly 4,000 research-use CBUs to 14 investigators at nine institutions, including: Memorial Sloan-Kettering Cancer Center, New York University, University of Illinois, Mount Sinai School of Medicine, Univer-sity of Minnesota, Rockefeller UniverUniver-sity, and UniverUniver-sity of Miami.

“We are heartened that more than 55,000

mothers have entrusted us with their precious

gifts of life.”

Pablo Rubinstein, MD

Vice President


c o r p o r a t e


c o m m u n i t y

r e l a t i o n s

William J. Mullaney, President of U.S. Business for MetLife, cuts the ribbon at NYBC’s donor coach launch event.


| 19

w h a t

w e

d o

m i l e s t o n e s

Our success as a Center of Excellence is only pos-sible through the strength of our partnerships. NYBC continues to build on a legacy of strong collaboration with a wide range of corporate and community organizations. We are privileged to partner with many individuals and organizations that are fundamental in helping us better serve our communities. Led by William J. Mullaney, President of U.S. Business for MetLife, our Vol-unteer Leadership Campaign engages scores of outstanding leaders from organizations commit-ted to NYBC. Since 1980, this program has been a critical source of influential and dedicated vol-unteers who reach out to others in a concerted effort to further our life-saving mission. From ex-ecutives at global corporations to baseball team

owners, public officials, high-ranking military officers, and leaders from educational and faith-based organizations, we rely on the work of this diverse cadre of volunteers. In addition to the vol-unteer campaign, our Blood Services Community Relations Advisory Council provides input and counsel across a wide array of activities, including blood donor recognition, general management assistance, customer service, and donor market-ing. Fundraising is also a feature of the work of our Corporate and Community Relations Depart-ment. Financial contributions help fund research at NYBC’s Lindsley F. Kimball Research Institute and National Cord Blood Program and further our work in blood, educational, and medical services.

The 2009 Biennial Chairman’s Dinner raised a record $1.4 million and saluted BNY Mellon and the X

New York Yankees as “Champions of Life” for their leadership and service to our organization. Employees of New York City, led by Mayor Michael Bloomberg and Commissioner Martha K. Hirst, X

continued to be NYBC’s largest source of blood donations, giving more than 35,000 gifts of life. The New York Yankees High School Blood Donor Championships 13th Annual Game Night cel-X

ebrated a record 62,000 annual donations made from New York and New Jersey high schools and 500,000 donations made since the program’s inception in 1996.

Despite a challenging economic climate, volunteer leadership maintained or grew support in key X

business sectors. From law firms to the real estate sector, and from financial services to nonprofit organizations, involvement of leadership made a positive impact and contribution to our mis-sion.

Our community and corporate partners provide

the support and leadership essential to both our

institution and our vital mission.


n y b c

l e a d e r s h i p

b o a r d o f t r u s t e e s William W. Crouse Harriet Edelman Owen Garrick, MD Christopher D. Hillyer, MD

Michael W. Hodin, PhD (not pictured)

Marc Kramer Aaron R. Marcu Howard P. Milstein

Seated from left to right: David Tendler, Owen Garrick, MD, Harriet Edelman, Nicholas Scoppetta, Aaron R. Marcu

Standing from left to right: William W. Crouse, Howard P. Milstein, Christopher D. Hillyer, John R. Mullen, Morton Spivack, Marc Kramer

John R. Mullen

Robert A. Schwartz (not pictured)

Nicholas Scoppetta Howard Sloan (not pictured)

Morton Spivack, MD (retired, October 2010)

David Tendler

John Zuccotti (not pictured)


| 21

e xe c u t i ve s t a f f

Christopher D. Hillyer, MD

President & Chief Executive Officer

Ollie Cheatham

Acting Senior Vice President Human Resources

Lawrence Hannigan

Vice President & Chief Financial Officer

Elizabeth J. McQuail

Senior Vice President Operations & Manufacturing

Mohandas Narla, DSc

Vice President

Director, Lindsley F. Kimball Research Institute

Robert Purvis

Vice President Customer Service

Eva Quinley, MS, MT(ASCP)SBB

Senior Vice President Quality & Regulatory Affairs

Pablo Rubinstein, MD

Vice President

Director, National Cord Blood Program

Jordana G. Schwartz

Acting General Counsel

Beth Shaz, MD

Vice President & Chief Medical Officer

Jay Valinsky, PhD

Vice President


b l o o d

d o n a t i o n

c e n t e r s

1 . 8 0 0 . 9 3 3 .

b l o o d

h u d s o n v a l l e y

Carmel Fire Department

94 Gleneida Avenue Carmel, NY 10512

Cronomer Valley Fire Department

North Plank Road Newburgh, NY 12550

Dan Leghorn Engine Company

426 South Plank Road Newburgh, NY 12550

Elmsford Donor Center

525 Executive Boulevard Elmsford, NY 10523

Hudson Valley Blood Services Donor Center

51 Albany Avenue Kingston, NY 12401

IBM 416 Building, Main Complex

Route 9 Poughkeepsie (Enter at 415 Lobby) Poughkeepsie, NY 12601

IBM East Fishkill Donor Center

Route 52, Building 320 Hopewell Junction, NY 12533

Lawrence Hospital

55 Palmer Avenue Bronxville, NY 10708

Middletown Community Donor Center

Howard Johnson’s 551 Route 211 East Middletown, NY 10940

Northern Westchester Hospital Donor Center

400 East Main Street (North Building, 1st Floor) Mt. Kisco, NY 10549

Rockland Blood Center

25 Smith Street Nanuet, NY 10954

Vassar Hospital Donor Center

45 Reade Place

Poughkeepsie, NY 12601

l o n g i s l a n d

Bohemia Donor Center

3125 Veterans Highway Bohemia, NY 11716

Lake Success Donor Center

2500 Marcus Avenue

(¼ mile east of Lakeville Road) Lake Success, NY 11042

Melville Donor Center

905 Walt Whitman Road

(Route 110, north of Northern State Parkway) Melville, NY 11747



Port Jefferson Station Donor Center

1010 Route 112

(100 yards south of Route 347) Port Jefferson Station, NY 11776

Riverhead Donor Center

1149 Old Country Road (Across from Target) Riverhead, NY 11901

Rockville Centre Donor Center

290 Sunrise Highway Rockville Centre, NY 11570 n e w j e r s e y

Clark Volunteer Emergency Squad

875 Raritan Road Clark, NJ 07066

Flemington Elks Lodge 1928

165 Route 31 Flemington, NJ 08822

New Brunswick Donor Center

167 New Street

New Brunswick, NJ 08901

Raritan Donor Center

(Platelets Only) 1001 Route 202 Raritan, NJ 08869

Scotch Plains Donor Center

2279 South Avenue Scotch Plains, NJ 07076 Somerville Elks 375 Union Avenue Somerville, NJ 08876 n e w yo r k

Brooklyn Donor Center

120 Lawrence Street Brooklyn, NY 11201

Citigroup Donor Center

53rd Street at Lexington Avenue Lower Level

New York, NY 10022

MetLife Donor Center

200 Park Avenue Lobby Level New York, NY 10166

New York Blood Center Headquarters Upper East Side Donor Center

310 East 67th Street (Between 1st & 2nd Avenue) First Floor Lobby

New York, NY 10065

Pergament Mall Donor Center

2791 Richmond Avenue (Above Verizon Wireless) Staten Island, NY 10314

Port Authority Donor Center

625 Eighth Avenue

(Between 40th & 41st Street) Main Floor

New York, NY 10018

Design/Copywriting | Chandler Wilson

Photography | Chris Herder Photography, Leslie Gonzalez, Chandler Wilson


m i s s i o n

To serve our community and provide the highest quality blood

and stem cell products, donor and patient medical services, and

innovative research.


v a l u e s









Sharing Knowledge

Maintaining Public Trust

v i s i o n

To develop people and partnerships to continue to be recognized

as a comprehensive center of excellence worldwide.


3 1 0 e a s t 6 7t h s t r e e t | n e w y o r k, n y 1 0 0 6 5 2 1 2 . 5 7 0 . 3 0 0 0 | n y b l o o d c e n t e r.o r g





Related subjects :